Mitro-aortic fibrosa pseudoaneurysm and concomitant aortic stenosis: How to kill two birds with a stone.
Alberto BoiGiovanni GarauAngelica RossiGiovanni LixiLaura ArmandiGiovanna Salvatorica FeleStefano CossaGildo MattaManlio ManconiFrancesco SannaBruno LoiPublished in: Journal of cardiac surgery (2020)
Pseudoaneurysm of mitral-aortic intervalvular fibrosa (P-MAIVF) is a rare acquired malformation of the mitral-aortic intervalvular area. It appears as a pulsatile cavity in the mitral-aortic junction communicating with the left ventricular outflow tract. P-MAIVF has been reported as a complication of aortic and mitral valve surgery, infective endocarditis, and thoracic trauma. It is associated with life-threatening complications. The recommended treatment is surgery, however, conservative therapy is an alternative approach for high-risk patients or when surgical treatment is refused. We describe a successfully exclusion of a P-MAIVF by transapical transcatheter aortic valve implantation in a patient with concomitant severe aortic stenosis.
Keyphrases
- aortic stenosis
- transcatheter aortic valve implantation
- aortic valve
- left ventricular
- mitral valve
- transcatheter aortic valve replacement
- aortic valve replacement
- ejection fraction
- left atrial
- minimally invasive
- hypertrophic cardiomyopathy
- acute myocardial infarction
- heart failure
- cardiac resynchronization therapy
- end stage renal disease
- coronary artery bypass
- pulmonary artery
- surgical site infection
- newly diagnosed
- peritoneal dialysis
- aortic dissection
- coronary artery disease
- mesenchymal stem cells
- spinal cord
- coronary artery
- percutaneous coronary intervention
- pulmonary arterial hypertension